Insiders · EVOK

EVOK insider transactions

Evoke Pharma Inc. (EVOK) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

EVOK insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Evoke Pharma Inc., latest first. Follow anyone to get their next filing.

• Nantahala Capital Management, LLC10% owner, since November 2024-$180
• Cam L GarnerDirector
• Benjamin C. SmealDirector, since October 2024
• Marilyn R. CarlsonChief Medical Officer
• Greg PyszczymukaDirector, since February 2025
• Matthew J D'OnofrioChief Executive Officer, Director
• Vickie S ReedDirector
• Todd C BradyDirector
• Malcolm R HillDirector
• Mark KowieskiChief Financial Officer, since May 2024
• Kenneth J WidderDirector
• Roger M. Klein10% owner, since November 2025-$95.9K
• David A GonyerOfficer, Director
• Ann D RhoadsDirector

Recent Form 3, 4, and 5 filings for EVOK

• 328d
  Large owner Nantahala Capital Management, Llc disposed of $1,629,683 worth of shares (148,153 units at $11.00) (SEC Form 4)

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 330d
  SEC Form 4 filed by Director Pyszczymuka Greg

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 330d
  Chief Medical Officer Carlson Marilyn R. closing all direct ownership in the company (SEC Form 4)

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 330d
  SEC Form 4 filed by Director Smeal Benjamin C.

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 330d
  SEC Form 4 filed by Director Garner Cam L

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 330d
  SEC Form 4 filed by Director Reed Vickie S

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 330d
  Director Brady Todd C closing all direct ownership in the company (SEC Form 4)

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 330d
  SEC Form 4 filed by Director Widder Kenneth J

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 330d
  Chief Executive Officer D'Onofrio Matthew J closing all direct ownership in the company (SEC Form 4)

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 330d
  Chief Financial Officer Kowieski Mark closing all direct ownership in the company (SEC Form 4)

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 330d
  Director Hill Malcolm R closing all direct ownership in the company (SEC Form 4)

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 370d
  Large owner Klein Roger M. sold $95,885 worth of shares (9,000 units at $10.65) (SEC Form 4)

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 371d
  New insider Klein Roger M. claimed ownership of 163,000 shares (SEC Form 3)

  3 - Evoke Pharma Inc (0001403708) (Issuer)
• 539d
  SEC Form 4 filed by Director Hill Malcolm R

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 539d
  SEC Form 4 filed by Director Brady Todd C

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 539d
  SEC Form 4 filed by Director Garner Cam L

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 539d
  SEC Form 4 filed by Director Smeal Benjamin C.

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 539d
  SEC Form 4 filed by Director Pyszczymuka Greg

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 539d
  SEC Form 4 filed by Director Reed Vickie S

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 539d
  SEC Form 4 filed by Director Widder Kenneth J

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 598d
  Chief Executive Officer D'Onofrio Matthew J was granted 1,000 shares, increasing direct ownership by 11% to 9,820 units (SEC Form 4)

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 598d
  Chief Financial Officer Kowieski Mark was granted 4,500 shares, increasing direct ownership by 1,082% to 4,916 units (SEC Form 4)

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 619d
  Chief Executive Officer D'Onofrio Matthew J was granted 6,849 shares, increasing direct ownership by 347% to 8,820 units (SEC Form 4)

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 626d
  SEC Form 4 filed by Director Pyszczymuka Greg

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 626d
  New insider Pyszczymuka Greg claimed no ownership of stock in the company (SEC Form 3)

  3 - Evoke Pharma Inc (0001403708) (Issuer)
• 651d
  Large owner Nantahala Capital Management, Llc sold $180 worth of shares (41 units at $4.39) (SEC Form 4)

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 652d
  SEC Form 4 filed by Chief Executive Officer D'Onofrio Matthew J

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 652d
  SEC Form 4 filed by Director Reed Vickie S

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 652d
  SEC Form 4 filed by Director Widder Kenneth J

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 652d
  SEC Form 4 filed by Director Brady Todd C

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 652d
  SEC Form 4 filed by Director Garner Cam L

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 652d
  SEC Form 4 filed by Director Hill Malcolm R

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 652d
  SEC Form 4 filed by Chief Financial Officer Kowieski Mark

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 652d
  SEC Form 4 filed by Chief Medical Officer Carlson Marilyn R.

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 727d
  New insider Nantahala Capital Management, Llc claimed ownership of 148,194 shares (SEC Form 3)

  3 - Evoke Pharma Inc (0001403708) (Issuer)
• 751d
  SEC Form 4 filed by Director Smeal Benjamin C.

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 751d
  New insider Smeal Benjamin C. claimed no ownership of stock in the company (SEC Form 3)

  3 - Evoke Pharma Inc (0001403708) (Issuer)
• 826d
  SEC Form 4 filed by Chief Financial Officer Kowieski Mark

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 826d
  SEC Form 4 filed by Chief Medical Officer Carlson Marilyn R.

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 826d
  SEC Form 4 filed by Chief Executive Officer D'Onofrio Matthew J

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 896d
  New insider Kowieski Mark claimed ownership of 5,000 shares (SEC Form 3)

  3 - Evoke Pharma Inc (0001403708) (Issuer)
• 902d
  SEC Form 4 filed by Hill Malcolm R

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 902d
  SEC Form 4 filed by Garner Cam L

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 902d
  SEC Form 4 filed by Reed Vickie S

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 902d
  SEC Form 4 filed by Widder Kenneth J

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 902d
  SEC Form 4 filed by Brady Todd C

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1281d
  SEC Form 4 filed by Widder Kenneth J

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1281d
  SEC Form 4 filed by Reed Vickie S

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1281d
  SEC Form 4 filed by Hill Malcolm R

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1281d
  SEC Form 4 filed by Garner Cam L

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1281d
  SEC Form 4 filed by Brady Todd C

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1371d
  SEC Form 4 filed by Gonyer David A

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1371d
  SEC Form 4 filed by D'Onofrio Matthew J

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1371d
  SEC Form 4 filed by Carlson Marilyn R.

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1659d
  SEC Form 4 filed by Widder Kenneth J

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1659d
  SEC Form 4 filed by Reed Vickie S

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1659d
  SEC Form 4 filed by Hill Malcolm R

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1659d
  SEC Form 4 filed by Garner Cam L

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1659d
  SEC Form 4 filed by Brady Todd C

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1742d
  SEC Form 4 filed by Gonyer David A

  4 - Evoke Pharma Inc (0001403708) (Issuer)